Refine by
Cancer Early Services
10 services found
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and ...
by:Envision Radiology based inColorado Springs, COLORADO (USA)
A mammogram procedure is simply an X-ray image of your breast. Mammography uses a low dose X-ray to look for early signs of breast cancer, such as lumps that are too small to be felt either by yourself or your healthcare provider. A mammogram can also show changes in your breast tissue which could indicate early-stage breast ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants completed a health questionnaire and provided a ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
Manufactured by:ImCare Biotech, LLC based inDoylestown, PENNSYLVANIA (USA)
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following surgical resection. Because recurrence of cancer often implies the immune ...
by:2M Engineering Ltd. based inValkenswaard, NETHERLANDS
Driving Innovation Through our comprehensive product creation services; At 2M, we are experts in creating cutting-edge smart sensing solutions that propel innovation in various industries. Our services encompass a wide range of offerings, from providing one-time consultancy or development projects to delivering full end-to-end product creation ...
by:Verana Health based inSan Francisco, CAMBODIA
Verana Health’s exclusive real-world data network and clinically true Qdata™ can help accelerate clinical trials in ophthalmology, urology, and neurology—from study startup through recruitment. From protocol development and clinical trial design to site selection and identifying potential participants*, we help speed patient enrollment to help you meet your recruitment goals. ...